Skip to main content
. 2018 Mar;24(3):10.18553/jmcp.2018.24.3.214. doi: 10.18553/jmcp.2018.24.3.214

TABLE 2.

Opioid Prescriptions Dispensed by Rhode Island Retail Pharmacies in 2015

Characteristic Number of Prescriptions (%) Prescription Cost, $ % Total Cost
Mean (SD) Median Total
Overall 651,227 67.98 (210.91) 21.08 44,271,827.00 100.00
Age group, years
  < 18 7,889 (1.21) 20.78 (41.63) 8.54 163,902.33 0.37
  18-24 22,794 (3.50) 15.45 (43.29) 7.02 352,063.77 0.80
  25-34 57,597 (8.84) 34.55 (145.80) 9.36 1,990,258.63 4.50
  35-44 84,085 (12.91) 61.08 (223.88) 16.47 5,135,736.95 11.60
  45-54 144,608 (22.21) 81.01 (247.86) 22.95 11,714,458.06 26.46
  55-64 162,352 (24.93) 90.07 (251.01) 25.32 14,622,945.43 33.03
  ≥ 65 171,902 (26.40) 59.87 (154.39) 22.95 10,292,461.84 23.25
Medication type
  Butorphanol 355 (0.05) 163.90 (109.88) 163.59 58,184.34 0.13
  Codeine based 37,100 (5.70) 6.86 (6.99) 4.43 254,557.96 0.57
  Fentanyl 15,169 (2.33) 204.43 (552.01) 126.66 3,101,069.73 7.00
  Hydrocodone 253,850 (38.98) 34.15 (54.21) 21.42 8,668,532.13 19.58
  Hydromorphone 9,717 (1.47) 209.70 (554.09) 18.23 2,037,677.97 4.60
  Levorphanol 9 (0.00) 560.08 (907.64) 103.12 5,040.76 0.01
  Meperidine 261 (0.04) 29.20 (24.95) 19.13 7,620.44 0.02
  Methadone 7,156 (1.10) 41.82 (32.23) 29.70 299,254.81 0.68
  Morphine 35,462 (5.45) 108.67 (267.76) 40.22 3,853,808.20 8.70
  Oxycodone 281,225 (43.18) 84.69 (235.80) 21.18 23,817,051.40 53.80
  Oxymorphone 1,810 (0.28) 595.72 (512.60) 439.68 1,078,255.85 2.44
  Pentazocine 341 (0.05) 173.27 (178.45) 178.75 59,084.86 0.13
  Tapentadol 1,103 (0.17) 492.86 (293.16) 421.98 543,626.74 1.23
  Othersa 7,669 (1.18) 63.64 (99.66) 38.16 488,061.81 1.10
MME dailyb
  ≤ 50 430,519 (66.11) 30.28 (53.62) 14.39 13,034,889.82 29.44
  50-90 135,105 (20.75) 70.26 (137.46) 28.51 9,492,612.15 21.44
  90+ 81,145 (12.46) 265.42 (513.27) 87.73 21,537,624.36 48.65
Generic or brand
  Generic 612,585 (94.07) 43.90 (116.21) 19.13 26,891,547.96 60.74
  Brand 38,642 (5.93) 449.78 (616.97) 279.43 17,380,279.05 39.26
Duration of action
  Short acting 579,849 (89.04) 38.27 (128.72) 16.47 22,190,457.00 50.12
  Long acting 71,378 (10.96) 309.36 (453.68) 136.26 22,081,370.01 49.88
Payment typec
  Commercial 332,088 (50.99) 65.55 (213.46) 19.00 21,769,832.09 49.17
  Medicare 191,554 (29.41) 85.31 (240.12) 28.08 16,341,749.85 36.91
  Medicaid 51,490 (7.91) 52.15 (154.24) 15.13 2,685,118.58 6.07
  Private pay 60,548 (9.30) 37.18 (97.84) 14.39 2,251,262.97 5.09
  Otherd 15,546 (2.39) 78.72 (234.92) 20.11 1,223,849.24 2.76

aPrimarily opioid-containing cough products (see Appendix B, available in online article).

bUnable to determine MME for 0.68% of observations.

cIf patient was aged ≥ 65 years with commercial insurance, then payment type was reclassified as Medicare. Method of payment was missing for 1 prescription.

dIncludes worker’s compensation, Indian Health Services, Veterans Health Administration, Tricare, and other federal sources.

MME = morphine milligram equivalent; SD = standard deviation.